AI tool could revolutionize lung cancer screening
NCT ID NCT07408531
First seen Feb 18, 2026 · Last updated May 13, 2026 · Updated 12 times
Summary
This study tests whether an artificial intelligence (AI) tool called Sybil can better predict lung cancer risk and help expand screening to more people. Researchers will enroll 2,500 adults aged 50-80 who are already getting lung scans. The goal is to see if AI and broader guidelines can catch lung cancer earlier in those who might otherwise be missed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER SCREENING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UI Health 55th and Pulaski Health Collaborative
RECRUITINGChicago, Illinois, 60629, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Illinois Cancer Center
RECRUITINGChicago, Illinois, 60612, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.